Vn. Ikoyev et al., RESULTS OF CONTROLLED TRIALS OF EXPERIMEN TAL RECOMBINANT LIVE VACCINE AGAINST HEPATITIS-B, Voprosy virusologii, 42(3), 1997, pp. 135-137
Experimental recombinant vaccine against hepatitis B Revacc B based on
vaccinia virus has been tried. The preparation was weakly reactogenic
bur did not induce the production of anti-HBsAg antibodies. On the ot
her hand, recombinant vaccine against hepatitis B Engerix B, used in a
blind experiment as the agent of comparison, induced the production o
f anti-HBs in 91% of vaccinees.